Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002128392-26-000003
Filing Date
2026-04-13
Accepted
2026-04-13 17:38:37
Documents
1
Period of Report
2026-04-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 7874
  Complete submission text file 0002128392-26-000003.txt   9359
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300-E WASHINGTON DC 20007
Business Address
Polymeropoulos Christos Vasilios Mihael (Reporting) CIK: 0002128392 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34186 | Film No.: 26858658